These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 15014030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
    Yanagawa T, Saito K, Kiyohara H, Ohno T, Nakano T, Takagishi K.
    Radiat Oncol; 2015 Dec 21; 10():259. PubMed ID: 26691334
    [Abstract] [Full Text] [Related]

  • 3. 11C-methionine-PET for evaluation of carbon ion radiotherapy in patients with pelvic recurrence of rectal cancer.
    Koizumi M, Saga T, Yoshikawa K, Suzuki K, Yamada S, Hasebe M, Ohashi S, Abd-Elrazek S, Ishikawa H, Sagou K, Tamura K, Hara R, Kato H, Yasuda S, Yanagi T, Tsujii H.
    Mol Imaging Biol; 2008 Dec 21; 10(6):374-80. PubMed ID: 18679757
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET.
    Hasebe M, Yoshikawa K, Ohashi S, Toubaru S, Kawaguchi K, Sato J, Mizoe J, Tsujii H.
    Mol Imaging Biol; 2010 Oct 21; 12(5):554-62. PubMed ID: 20369300
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.
    Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe JE, Miyamoto T, Kato H, Yamada S, Morita S, Yoshikawa K, Kandatsu S, Tateishi A, Working Group for the Bone and Soft Tissue Sarcomas.
    J Clin Oncol; 2002 Nov 15; 20(22):4466-71. PubMed ID: 12431970
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
    Andersen KF, Fuglo HM, Rasmussen SH, Petersen MM, Loft A.
    Medicine (Baltimore); 2015 Jul 15; 94(28):e1142. PubMed ID: 26181552
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of 11C-methionine-PET for predicting the efficacy of carbon ion radiation therapy for head and neck mucosal malignant melanoma.
    Hasebe M, Yoshikawa K, Nishii R, Kawaguchi K, Kamada T, Hamada Y.
    Int J Oral Maxillofac Surg; 2017 Oct 15; 46(10):1220-1228. PubMed ID: 28535963
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Complication rate, functional outcomes, and risk factors associated with carbon ion radiotherapy for patients with unresectable pelvic bone sarcoma.
    Takenaka S, Araki N, Outani H, Hamada KI, Yoshikawa H, Kamada T, Imai R.
    Cancer; 2020 Sep 15; 126(18):4188-4196. PubMed ID: 32658315
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.